Completed PHASE3 INTERVENTIONAL 2-arm NCT01391091

Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine (CONFIRM)

Effect of Catheter Ablation on the Prevalence, Clinical Manifestation and MRI Findings of Migraine in AF Patients With or Without a Previous History of Migraine

Sponsor: Texas Cardiac Arrhythmia Research Foundation

Conditions Atrial Fibrillation Migraine

Interventions Radiofrequency catheter ablation

Updated 6 times since 2017 Last updated: Oct 17, 2016 Started: Dec 31, 2010 Primary completion: Apr 30, 2013 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Atrial Fibrillation and Migraine and is currently completed. Texas Cardiac Arrhythmia Research Foundation leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Texas Cardiac Arrhythmia Research Foundation

Data source: Texas Cardiac Arrhythmia Research Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Austin, United States